• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Oral platelet glycoprotein IIb/IIIa receptor antagonists: the present challenge is safety.

作者信息

Vorchheimer D A, Fuster V

出版信息

Circulation. 1998 Feb 3;97(4):312-4. doi: 10.1161/01.cir.97.4.312.

DOI:10.1161/01.cir.97.4.312
PMID:9468202
Abstract
摘要

相似文献

1
Oral platelet glycoprotein IIb/IIIa receptor antagonists: the present challenge is safety.
Circulation. 1998 Feb 3;97(4):312-4. doi: 10.1161/01.cir.97.4.312.
2
Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Thrombolysis in Myocardial Infarction.急性冠状动脉综合征患者口服血小板糖蛋白IIb/IIIa拮抗剂西拉非班的随机试验：心肌梗死溶栓治疗（TIMI）12试验结果
Circulation. 1998 Feb 3;97(4):340-9. doi: 10.1161/01.cir.97.4.340.
3
Glycoprotein IIb/IIIa antagonists in acute coronary syndromes.急性冠状动脉综合征中的糖蛋白IIb/IIIa拮抗剂
Haematologica. 2001 Nov;86(11 Suppl 2):45-8.
4
Oral platelet IIb/IIIa inhibitors: from attractive theory to clinical failures.口服血小板IIb/IIIa抑制剂：从诱人的理论到临床失败
J Thromb Thrombolysis. 2000 Dec;10(3):217-20. doi: 10.1023/a:1026582821645.
5
Oral glycoprotein IIb/IIIa antagonism in patients with coronary artery disease.冠心病患者口服糖蛋白IIb/IIIa拮抗剂的研究
Am J Cardiol. 2001 Aug 1;88(3):236-42. doi: 10.1016/s0002-9149(01)01632-0.
6
Oral glycoprotein IIb/IIIa antagonists: new insights from the SYMPHONY trial.口服糖蛋白IIb/IIIa拮抗剂：SYMPHONY试验的新见解。
J Thromb Thrombolysis. 2000 Oct;10(2):111-9. doi: 10.1023/a:1018782708070.
7
A perspective on the toxicological mechanisms possibly contributing to the failure of oral glycoprotein IIb/IIIa antagonists in the clinic.关于可能导致口服糖蛋白IIb/IIIa拮抗剂临床应用失败的毒理学机制的观点。
Am J Cardiovasc Drugs. 2004;4(1):1-10. doi: 10.2165/00129784-200404010-00001.
8
Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both?非ST段抬高型急性冠脉综合征及经皮冠状动脉介入治疗中的血小板抑制剂：糖蛋白IIb/IIIa抑制剂、氯吡格雷，还是两者联用？
Vasc Health Risk Manag. 2006;2(1):39-48. doi: 10.2147/vhrm.2006.2.1.39.
9
Oral GPIIb/IIIa antagonists: what went wrong?口服糖蛋白IIb/IIIa拮抗剂：问题出在哪里？
Curr Pharm Des. 2004;10(14):1587-96. doi: 10.2174/1381612043384673.
10
Sustained platelet glycoprotein IIb/IIIa blockade with oral xemilofiban in 170 patients after coronary stent deployment.170例冠状动脉支架置入术后患者口服西美罗非班持续抑制血小板糖蛋白IIb/IIIa活性的研究
Circulation. 1997 Aug 19;96(4):1117-21. doi: 10.1161/01.cir.96.4.1117.

引用本文的文献

1
Cell adhesion molecules: potential therapeutic & diagnostic implications.细胞黏附分子：潜在的治疗与诊断意义
Mol Biotechnol. 2008 Jan;38(1):33-40. doi: 10.1007/s12033-007-0072-7. Epub 2007 Aug 15.
2
Platelet glycoprotein IIb/IIIa receptor antagonists: current concepts and future directions.
Drugs. 1999 Dec;58(6):965-82. doi: 10.2165/00003495-199958060-00002.
3
Platelet-endothelial interactions in atherothrombotic disease: therapeutic implications.动脉粥样硬化血栓形成疾病中的血小板-内皮细胞相互作用：治疗意义
Clin Cardiol. 1999 Nov;22(11):687-98. doi: 10.1002/clc.4960221103.
4
Glycoprotein IIb/IIIa receptor antagonists in non-ST elevation acute coronary syndromes and percutaneous revascularisation: a review of trial reports.
Drugs. 1999 Oct;58(4):609-20. doi: 10.2165/00003495-199958040-00003.
5
Emerging treatment of acute coronary syndromes with platelet glycoprotein IIB/IIIA inhibitors.
J Thromb Thrombolysis. 1999 Jun;7(3):247-57. doi: 10.1023/a:1008927025962.